General viral replication machinery

The general viral replication machinery refers to the collective ensemble of viral and host-derived proteins required for the replication of a virus's genetic material and the assembly of new virions (Nature Reviews Microbiology, 2020). This machinery typically includes key enzymes such as polymerases (RNA-dependent RNA polymerase or DNA polymerase), helicases, proteases, and integrases, which work in a coordinated fashion within specialized cellular compartments often referred to as viral replication complexes (VRCs) (PMID: 32735548). Because these components are essential for the viral life cycle and often lack direct human homologs, they serve as primary targets for a wide range of antiviral therapies. Drugs targeting this machinery, such as nucleoside analogs (e.g., Remdesivir) or protease inhibitors (e.g., Ritonavir), aim to disrupt specific steps like genome synthesis or polyprotein processing (PMID: 32245903). However, the high mutation rates of many viruses, particularly RNA viruses, frequently lead to the emergence of resistance, posing a significant challenge for long-term treatment efficacy. Additionally, ensuring selectivity to avoid inhibiting host cell processes, such as mitochondrial DNA replication, is a critical safety consideration in drug development (PMID: 21642992).

Other names

Viral replication complexViral replicaseViral replication apparatusViral replication proteinsReplicase-transcriptase complex

Inhibition of essential viral enzymes including RNA-dependent RNA polymerases (RdRp), DNA polymerases, proteases, and integrases to halt the viral life cycle and prevent the production of infectious progeny (PMID: 32735548, PMID: 32245903).